Cargando…
Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles
The wide tissue distribution of the adrenergic β3 receptor makes it a potential target for the treatment of multiple pathologies such as diabetes, obesity, depression, overactive bladder (OAB), and cancer. Currently, there is only one drug on the market, mirabegron, approved for the treatment of OAB...
Autores principales: | Lorca, Marcos, Morales-Verdejo, Cesar, Vásquez-Velásquez, David, Andrades-Lagos, Juan, Campanini-Salinas, Javier, Soto-Delgado, Jorge, Recabarren-Gajardo, Gonzalo, Mella, Jaime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099677/ https://www.ncbi.nlm.nih.gov/pubmed/29772697 http://dx.doi.org/10.3390/molecules23051191 |
Ejemplares similares
-
CoMFA and CoMSIA 3D-QSAR analysis of DMDP derivatives as anti-cancer agents
por: Srivastava, Vivek, et al.
Publicado: (2008) -
3D-QSAR Studies on Thiazolidin-4-one S1P(1) Receptor Agonists by CoMFA and CoMSIA
por: Qian, Chuiwen, et al.
Publicado: (2011) -
CoMFA, CoMSIA and Eigenvalue Analysis on Dibenzodioxepinone and Dibenzodioxocinone Derivatives as Cholesteryl Ester Transfer Protein Inhibitors
por: Xiong, Xu-qiong, et al.
Publicado: (2008) -
CoMFA, CoMSIA, HQSAR and Molecular Docking Analysis of Ionone-based Chalcone Derivatives as Antiprostate Cancer Activity
por: Sharma, R., et al.
Publicado: (2016) -
Structural Insights on Hyp-Gly-Containing Peptides as Antiplatelet Compounds through Topomer CoMFA and CoMSIA Analysis
por: Yang, Yijie, et al.
Publicado: (2023)